Top Stories

Netflix, Inc. (NASDAQ: NFLX) is touching all-time highs yet again after topping sales estimates in the third quarter. The streaming media provider reported third-quarter sales of $2.985 billion, beating consensus estimates by $15 million. Third-quarter GAAP earnings missed by 3 cents, at 29 cents...

Analysts at Oppenheimer presented a list of the firm's top equity ideas. Each analyst that covers a unique sector presented their one best idea that is likely to outperform over the next 12 months. 29 Sizzling Stock Ideas 1. Estee Lauder Companies Inc (NYSE: EL) is benefiting from ongoing momentum...

Retail stocks remain under pressure and the related exchange-traded fund, the SPDR S&P Retail (ETF) (NYSE: XRT), saw one of its worst trading weeks since the end of December. While many investors remain concerned of retail's ongoing woes, the weakness could be seen as a buying opportunity...

Many investors aren't familiar with the term "snake pit," but for Procter & Gamble Co (NYSE: PG) investors, this term will likely be mentioned often moving forward. A snake pit is used by participants in a proxy-fight battle to describe the process of investigating contested votes, CNBC...

IN THE NEWS Benzinga Drug distributors were in freefall Friday when CBS teased Sunday's expository “60 Minutes” episode linking these distributors to failures in the opioid crackdown: Link Anyone with an online trading account can buy and sell shares of most publicly-traded...

One of the hottest corners of the fixed income market is positioned to continue delivering upside as the U.S. dollar remains lethargic and bond investors continue embracing higher-yielding opportunities. Emerging markets debt is on a torrid pace of performance and, when it comes to exchange-traded...

President Donald Trump ramped up his criticism of the NFL this week, calling out the league for taking advantage of “massive tax breaks” after repeatedly condemning the league for allowing players to protect the national anthem. Trump failed to clarify which tax breaks he was referring...

In the rare books room at the mammoth store that bears his name, John King reveals a page from the volume that changed the world. “This put the monks out of business,” King said, with type from the Gutenberg Bible on the desk in front of him. John K. King Used & Rare Books, in...

On Thursday afternoon, and FDA advisory panel recommended approval of Spark Therapeutics Inc (NASDAQ: ONCE)’s Luxturna treatment for inherited blindness. A number of Wall Street analysts weighed in on the stock following the news. Here’s an overview of what they had to say. Voices...

With the stock under pressure in early Friday trading, Square Inc (NYSE: SQ) investors are at risk of seeing something in their portfolio they haven’t seen in nearly three weeks: the color red. Since the stock last closed in the red on Sept. 22, Square has delivered an incredible 14...

Bank of America Corp (NYSE: BAC) on Friday reported third-quarter earnings, which initially sent shares lower. However, the company's earnings were very much "solid" and investors aren't appreciating the stock's attractive valuation, Buckingham Research Group's James...

The retirement of Hostess Brands, Inc. (NASDAQ: TWNK) CEO Bob Toler isn’t bittersweet. It’s just bitter, according to UBS. “We view Toler as the driving force behind Hostess' turnaround success and view his departure (plus recent COO departure) as concerns,” analyst...

IN THE NEWS Benzinga Twitter Inc (NYSE: TWTR) reversed a temporary suspension on actress Rose McGowan’s account Thursday after fielding backlash for censoring a voice decrying sexual harassment: Link It’s hard to imagine that Ulta Beauty Inc (NYSE: ULTA) stock was trading above $314...

Analysts at Cantor Fitzgerald continue to hold a bullish stance on Spark Therapeutics Inc (NASDAQ: ONCE) after the U.S. Food and Drug Administration gave the company a critical recommendation for its therapy called Luxturna. Analyst Elemer Piros maintains an Overweight rating on Spark's stock...

H.C. Wainwright has initiated bullish coverage of four healthcare stocks headed into the end of 2017. Analyst Edward White explained his positive take on the four stocks in a research note on Thursday. Here’s a rundown of what he had to say. Acceleron Pharma - Buy White said the future of...